Table 3.
Comparison of baseline variables between first-pass TICI 2c-3 vs. non-first-pass TICI 2c-3.
| Variable | FP TICI 2c-3 (n = 62) | Non-FP TICI 2c-3 (n = 59) | P-value |
|---|---|---|---|
| Age (years); mean ± SD | 67.2 ± 12.8 | 66.6 ± 14.0 | 0.78 |
| Female sex; n (%) | 36 (58.1%) | 36 (61.0%) | 0.74 |
| Baseline NIHSS score; median (IQR) | 16.5 (12–19) | 17 (14–21) | 0.36 |
| Baseline NCCT ASPECTS; median (IQR) (n = 94) | 10 (9.5–10) (n = 48) | 10 (9–10) (n = 46) | 0.80 |
| Occlusion level; n (%) | |||
| ICA | 14 (22.6%) | 13 (22.0%) | 0.94 |
| MCA M1 | 48 (77.4%) | 46 (78.0%) | |
| IV tPA treatment; n (%) | 38 (61.3%) | 44 (74.6%) | 0.12 |
| Hypertension; n (%) | 44 (71.0%) | 40 (67.8%) | 0.71 |
| Diabetes mellitus; n (%) | 12 (19.4%) | 11 (18.6%) | 0.92 |
| Atrial fibrillation; n (%) | 22 (35.5%) | 25 (42.4%) | 0.44 |
| Dyslipidemia; n (%) | 22 (35.5%) | 26 (44.1%) | 0.34 |
| Smoking; n (%) | 13 (21.0%) | 18 (30.5%) | 0.23 |
| Previous stroke/transient ischemic attack; n (%) | 11 (17.7%) | 9 (15.3%) | 0.71 |
| Previous MI/CAD; n (%) | 18 (29.0%) | 11 (18.6%) | 0.18 |
FP, first-pass; IV tPA, intravenous tissue plasminogen activator; IQR, interquartile range; MI/CAD, myocardial infarction/coronary artery disease; NCCT ASPECTS, non-contrast CT Alberta Stroke Program Early CT Score; NIHSS, National Institutes of Health Stroke Scale; SD, standard deviation; TICI, Treatment in Cerebral Ischemia scale.